Today we will review Merck & Co stocks as I have promised recently. The company announced the launch of the first oral medication against COVID-19 with proven efficiency.
Let’s analyse the chart with the Merck stocks and their upside potential.
When doing analysis it is traditionally better to start from the eldest timeframes to distinguish the existing trend....
Live Nation Entertainment
Live Nation Entertainment, Inc. is an entertainment company, which engages in producing, marketing and selling live concerts for artists via global concert pipe. It operates through the following segments: Concerts, Sponsorship & Advertising and Ticketing. The Concerts segment involves in the promotion of live music events in owned or...
This is my end cycle market thesis.
I know you can't predict market tops or timing.
I'm just trying to include potential reactions to FED tapering and FED rake hikes in conjunction with an end to a long bull market run, Covid crysis and CBDC announcments.
Based on the Weekly chart...
There was NO end to the wave, a slight reprieve, but it was there, clear and present.
Sine the week of 19 July, it was a crossover, one that is significant and not to ignore. On the week of 30 August, the uptick was telling that the trend is real and resuming.
Now SG would really feel it now as the rate is clearly accelerating over...
First off, this is not meant as any opinion towards Covid-19 (political, medical, or otherwise) nor meant in any way to dishonor any who have lost loved ones due to Covid-19, but rather I wanted to call out an interesting correlation that looks to be occurring.
Recently TradingView made the confirmed cases in the US available broken down per state or country....
Nothing is more profitable than fear.
I think Pfizer profits have doubled by Q2 and it's getting even crazier, way crazier.
The whole west is throwing money at them with government and most urbanites in total fear.
They don't even care how much it costs. Destroy a country? Lose 10% of GDP? They don't care, just name your price.
Take AMZN for example. Went...
On 6/11/2021 Piper Sandler brokerage Initiated Coverage giving a price target of $18.00
VXRT Vaxart today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier. (prnewswire.com)
This is in...
Biotech sector is getting hot, especially for companies connected to COVID-19 vaccine and treatments development... BIOV chart looks rip for a breakout with MACD closing in on bullish cross and a major catalyst in the form of FDA approval of its Phase I/II study:
FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical...
Good news and even better volume today. We should see this build a base around $10 - $12. Earnings on the 29th should be interesting.
VWAP rejected and momentum slowed down.
Long $IPA. There is no way big pharma doesn't like this play.
On 4/20/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $16.00 for NRBO
But how come? What`s the catalyst? Why NeuroBo Pharmaceuticals was up 40% yesterday?
Richard J. Kang, CEO: "Throughout the first quarter of 2021, we continued to make progress advancing the 60-patient Phase 2/3 clinical trial of our lead drug candidate, ANA001,...
Position: long Entry price: 18.5
Target price: 28 Stop loss: 19
RSI is very low under 25, better to wait till the price reaches the support line around 18.
Bullinger Bands and William Alligator are really opened, indicating a strong trend. So the price will probably reach the support.
ADX is really strong, indicating a strong...
Looming concerns over the Delta covid variant probes the UK’s total unlock on July 19 as the infections jump to the highest since January. The same drag the GBPUSD prices to break the monthly rising channel, confirming the bearish flag chart pattern in turn. Given the MACD conditions also supporting the sellers and the RSI line having a bit gap from the oversold...
Here we have the lifetime chart for ASX:CAT.
- Starting with a price of $0.63 and reaching an ATH of $4.26 in only 1 year.
- It then went on a 3 year downtrend back to its original $0.63.
- After that we see it recover to $2.13 in 1 year.
- COVID-19 pandemic brings price all the way down to $0.49, which is its new ATL.
- Since then price has recovered...
From the previous post on 14 May, I was doing a friend a favour into looking at the UK projection as she is living in London.
I said "... and projection made that the start of a spike is at the end of June, into July .
IF this projection is on point, then outnbreak news should be seen in the latter part of July ."
It is the beginning of July, and it appears...
Previously projected to explode in mid-June, with clear media coverage about the next wave.
Today, the last day of June, in the media - I ndonesia's COVID-19 situation nears 'catastrophe', says Red Cross
The model here is good at projecting with at least a 4 weeks lead time for potential waves. This was previously demonstrated for a couple of countries and all...
KNR has been beaten down but looks way overdone, given they have just raised $8.5 at 1.50 with institutional investors. The company reported respectable $3.3M revenues in Q1 2021. Their BioCloud COVID-19 detection device will be used by the Canadian Olympic delegation at the Tokyo Olympics. The US sales channel is being worked on. Insiders are buying in the open...